Starlight Cardiovascular: Raises $9.48M in Series A Financing

Starlight Cardiovascular Raises $9.48M in Series A Financing

• Starlight Cardiovascular, a San Diego, CA-based preclinical stage medical technology company, raised $9.48M in Series A funding
• The round, which included conversion of previously-issued notes, was led by Bird B
• The company intends to use the funds to progress development of its portfolio of pediatric interventional cardiology devices
• StarlightCardiovascular is a preclinical stage medical technology company developing a portfolio of devices to address pediatric Congenital Heart Disease
• Its first product, a Ductus Arteriosus Stent, replaces a life-saving open chest surgery with a microcatheter-based procedure performed through a small incision in the skin